Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Millennium Biologics was a Canadian biotechnology company specializing in the development of advanced biomaterials for bone repair and regeneration. The company's core technology, Skelite, is a silicon-stabilized calcium phosphate synthetic bone graft substitute designed to mimic the composition and structure of natural bone. Skelite's unique properties allow it to be resorbed by osteoclasts and replaced by natural bone during the remodeling process. The company's products were primarily used in orthopedic and spinal surgeries to treat bone defects. Millennium Biologics was acquired by Interpore International in 2004, which was subsequently acquired by Biomet (now Zimmer Biomet).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Millennium Biologics.